# SARcode Bioscience Inc.: Form D filings

SARcode Bioscience Inc., a biotechnology company in Brisbane, CA, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on July 18, 2011, reports $43.6 million sold of a $43.6 million offering to 9 investors.

Find out what SARcode Bioscience Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SARcode%20Bioscience%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SARcode%20Bioscience%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsarcode-bioscience-inc-1386215)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SARcode%20Bioscience%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SARcode%20Bioscience%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsarcode-bioscience-inc-1386215)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1000 MARINA PARKWAY, SUITE 250, Brisbane, CA, 94005
- Phone: (650) 416-7560
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2006
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1386215

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 18, 2011 | New notice | $43,579,049 | $43,579,049 | $0 | 9 | Jul 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1386215/000138621511000002/0001386215-11-000002-index.htm) |
| Dec 23, 2009 | Amendment | $29,000,000 | $29,000,000 | $0 | 7 | Dec 21, 2006 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1386215/000138621509000004/0001386215-09-000004-index.htm) |
| Nov 12, 2009 | Amendment | $27,000,000 | $27,000,000 | $0 | 7 | Dec 21, 2006 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1386215/000138621509000003/0001386215-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Quinton Oswald | Executive Officer, Director |  |
| Todd A Creech | Executive Officer |  |
| Charles Semba | Executive Officer |  |
| Mary A Newman | Executive Officer |  |
| Martin A Vogelbaum | Director |  |
| Thomas Gadek | Director |  |
| Garheng A Kong | Director |  |
| Valerie A Smith | Executive Officer |  |
| Dennis Henner | Director |  |
| Robert Alexander | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of Jul 18, 2011](https://specstream.ai/data/form-d/week/2011-07-18) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what SARcode Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).